After Backlash, Teva Will Resume Production of Vincristine After Backlash, Teva Will Resume Production of Vincristine

Only a few months after announcing that it will cease production of this essential medicine for childhood cancers, Teva has announced it will jump back into the market.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news